Ethacrynate sodium
利尿酸钠
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameEthacrynate sodium
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1967/01/10
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A
Develop Information
Active CompaniesBausch & Lomb (Singapore) Pvi Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A